Opko Health, Inc.

311 articles about Opko Health, Inc.

• Opko Health Announces Move To NASDAQ Stock Market

  6/13/2016

• Opko Health To Discuss Draft Coverage Determinations For 4Kscore Test At 2016 Jefferies Healthcare Conference

  6/8/2016

• Opko Health To Present At The 2016 Jefferies Healthcare Conference

  6/2/2016

• Opko Health Receives Proposed/Draft Medicare Local Coverage Determination For 4KScore Test

  5/27/2016

• 3 Life Science Stocks Short-Sellers are Wrong About

  5/20/2016

• Opko Health Announces Appointment Of Douglass Laidlaw As Vice President Of Medical Affairs

  5/11/2016

• Opko Health Reports First Quarter Financial And Operating Results

  5/10/2016

• Opko Health, Vifor Fresenius Medical Care Renal Pharma Forge $282 Million+ RAYALDEE Deal

  5/9/2016

• Opko Health To Announce First Quarter Operating And Financial Results On May 9, 2016

  4/29/2016

• Opko Health Release: FDA Accepts Resubmission Of New Drug Application For RAYALDEE

  4/28/2016

• Opko Health Presents Additional Data On RAYALDEE At National Kidney Foundation Spring Clinical Meetings 2016

  4/28/2016

• Opko Health Announces Appointment Of James Demarco As Senior Vice President Of Pharmaceutical Sales

  4/25/2016

• Opko Health Presents Additional Data On Rayaldee At ENDO 2016

  4/1/2016

• Opko Health Presents Additional Data On RAYALDEE To Treat Secondary Hyperparathyroidism In Chronic Kidney Disease

  3/31/2016

• Opko Health Falls as the FDA Halts Approval of Rayaldee

  3/30/2016

• Opko Health Announces Executive Appointment

  3/28/2016

• Opko Health Announces Dosing Of First Subject In Phase I Clinical Study Of A Long-Acting Oxyntomodulin For The Treatment Of Obesity And Type II Diabetes

  3/16/2016

• Opko Health 4Kscore Recommended In 2016 European Association Of Urology Prostate Cancer Guidelines

  3/16/2016

• Opko Health Names Dr. Gregory Henderson President Of Bio-Reference Laboratories

  3/15/2016

• Five Companies Face Big FDA Decisions This Month

  3/14/2016